Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)

NCT00538239 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

711

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Soft-Tissue Sarcomas
Metastatic Bone Sarcomas

Interventions

DRUG: ridaforolimus
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]